Two Sigma Securities, LLC Clovis Oncology, Inc. Call Options Transaction History

Two Sigma Securities, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $128,426 - $276,078	-26,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $110,271 - $171,147	26,700 New	26,700 $128,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $63,336 - $184,800	-16,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $50,400 - $276,024	16,800 New	16,800 $175,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.